Abstract In the recent Bone Key Reports review, it was noted that combinations of anabolic
and antiresorptive agents have potential to improve bone density and bone strength more …

Combinations of anabolic and antiresorptive agents have potential to improve bone density
and bone strength more than either agent alone. A large number of relatively small clinical …

The effects of anabolic medications (teriparatide [TPTD] and parathyroid hormone [PTH])
differ in patients who have received recent treatment with potent antiresorptives. This …

As osteoporosis therapy options have expanded, and clinical guidelines have begun to
embrace the concept of limited treatment courses and “drug holidays,” the choices that …

Objective: Provide an update regarding anabolic medications for osteoporosis, which are
often considered to be the last resort for patients with osteoporosis, after multiple fractures …

Over the past three decades, the mainstay of treatment for osteoporosis has been
antiresorptive agents (such as bisphosphonates), which have been effective with continued …

Efficient therapies are available for the treatment of osteoporosis. Anti‐resorptive therapies,
including bisphosphonates and denosumab, increase bone mineral density (BMD) and …

Efficient therapies are available for the treatment of osteoporosis, however, there are still
unmet needs. Anti-resorptive therapies only increase bone mineral density to a certain …

In this paper, we focus upon the use of anabolic skeletal therapy for the treatment of
postmenopausal and other forms of osteoporosis. The only anabolic skeletal agent currently …

Despite the availability of safe and effective anti-osteoporosis treatments, osteoporosis
continues to be undertreated. The increase in fragility fractures, which is the main clinical …